Phase 3 Results of Bavarian Nordic’s Smallpox Vaccine Published in The New England Journal of Medicine

NEXT STORY
Helsinn supported ‘70 Years of Cancer Care in China’ celebratory event in Shanghai
PREV STORY
Curetis Provides Business Update for the First Nine Months of 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CymaBay Therapeutics Presents Positive Phase 2 Data for Seladelpar in Patients with Primary Biliary Cholangitis at the International Liver Congress™ 2019

author_avatar
NASDAQ Market News

EMA Grants Orphan Drug Designation to Rafael Pharmaceuticals’ devimistat (CPI-613®) for Treatment of Metastatic Pancreatic Cancer

Newark, NJ, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in ...

author_avatar
NASDAQ Market News

GeoVax’s Chief Scientific Officer to Speak at World Vaccine Congress

GeoVax Also Nominated for Vaccine Industry Excellence Awards Atlanta, GA, March 26, 2018 (GLOBE ...

author_avatar
NASDAQ Market News